These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

121 related articles for article (PubMed ID: 2485597)

  • 1. Clinical tests as predictors of growth response in GH treatment of short normal children.
    Hagenäs L
    Acta Paediatr Scand Suppl; 1989; 362():36-43. PubMed ID: 2485597
    [No Abstract]   [Full Text] [Related]  

  • 2. Predictors of first-year growth response to a fixed-dose growth hormone treatment in children born small for gestational age: results of an open-label, multicenter trial in the United States.
    Rapaport R; Saenger P; Wajnrajch MP;
    J Pediatr Endocrinol Metab; 2008 May; 21(5):411-22. PubMed ID: 18655522
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Predictors of growth response to growth hormone in otherwise normal short children.
    Zadik Z; Landau H; Limoni Y; Lieberman E
    J Pediatr; 1992 Jul; 121(1):44-8. PubMed ID: 1625091
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Prediction of the growth response of short prepubertal children treated with growth hormone. Swedish Paediatric Study Group for GH treatment.
    Kriström B; Karlberg J; Albertsson-Wikland K
    Acta Paediatr; 1995 Jan; 84(1):51-7. PubMed ID: 7734899
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Growth hormone treatment in non-growth hormone-deficient children: effects of stopping treatment.
    Ackland FM; Jones J; Buckler JM; Dunger DB; Rayner PH; Preece MA
    Acta Paediatr Scand Suppl; 1990; 366():32-7. PubMed ID: 2206005
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Free/dissociable insulin-like growth factor (IGF)-I, not total IGF-I, correlates with growth response during growth hormone treatment in children born small for gestational age.
    Bannink EM; van Doorn J; Mulder PG; Hokken-Koelega AC
    J Clin Endocrinol Metab; 2007 Aug; 92(8):2992-3000. PubMed ID: 17504895
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Bone alkaline phosphatase and collagen markers as early predictors of height velocity response to growth-promoting treatments in short normal children.
    Crofton PM; Stirling HF; Schönau E; Kelnar CJ
    Clin Endocrinol (Oxf); 1996 Apr; 44(4):385-94. PubMed ID: 8706304
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effects of growth hormone in short, slowly growing children without growth hormone deficiency. Australasian Paediatric Endocrine Group.
    Cowell CT
    Acta Paediatr Scand Suppl; 1990; 366():29-30; discussion 31. PubMed ID: 2206004
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Growth velocity, final height and bone mineral metabolism of short children treated long term with growth hormone.
    Lanes R
    Curr Pharm Biotechnol; 2000 Jul; 1(1):33-46. PubMed ID: 11467359
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Growth hormone treatment in short children--short-term and long-term effects on growth.
    Albertsson-Wikland K
    Acta Paediatr Scand Suppl; 1988; 343():77-84. PubMed ID: 3195335
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Increased response, but lower responsiveness, to growth hormone (GH) in very young children (aged 0-3 years) with idiopathic GH Deficiency: analysis of data from KIGS.
    Ranke MB; Lindberg A; Albertsson-Wikland K; Wilton P; Price DA; Reiter EO
    J Clin Endocrinol Metab; 2005 Apr; 90(4):1966-71. PubMed ID: 15634724
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Efficacy and safety of growth hormone treatment in children born small for gestational age in Japan.
    Tanaka T; Fujieda K; Yokoya S; Seino Y; Tada H; Mishina J
    J Pediatr Endocrinol Metab; 2008 May; 21(5):423-31. PubMed ID: 18655523
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Growth hormone therapy in achondroplasia.
    Nishi Y; Kajiyama M; Miyagawa S; Fujiwara M; Hamamoto K
    Acta Endocrinol (Copenh); 1993 May; 128(5):394-6. PubMed ID: 8317186
    [TBL] [Abstract][Full Text] [Related]  

  • 14. GH treatment induces sustained catch-up growth in children with intrauterine growth retardation: 7-year results.
    Albanese A; Stanhope R
    Horm Res; 1997; 48(4):173-7. PubMed ID: 9378463
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Growth hormone treatment and the short child: to treat or not to treat?
    Bercu BB
    J Pediatr; 1987 Jun; 110(6):991-5. PubMed ID: 3295165
    [No Abstract]   [Full Text] [Related]  

  • 16. Final height after growth hormone therapy in non-growth-hormone-deficient children with short stature.
    Loche S; Cambiaso P; Setzu S; Carta D; Marini R; Borrelli P; Cappa M
    J Pediatr; 1994 Aug; 125(2):196-200. PubMed ID: 8040761
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Growth prediction models, concept and use.
    Kriström B; Wikland KA
    Horm Res; 2002; 57 Suppl 2():66-70. PubMed ID: 12065931
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effectiveness of growth hormone (GH) therapy in GH-deficient children and non-GH-deficient short children.
    Bozzola M; Cisternino M; Biscaldi I; Maghnie M; Valtorta A; Moretta A; Severi F
    Eur J Pediatr; 1988 Apr; 147(3):248-51. PubMed ID: 3292246
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Renal handling of phosphate can predict height velocity during growth hormone therapy for short children.
    Nishiyama S; Ikuta M; Nakamura T; Tomoeda S; Matsuda I
    J Clin Endocrinol Metab; 1992 Apr; 74(4):906-9. PubMed ID: 1548358
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Can growth hormone treatment increase final height in constitutional short stature?
    Ivarsson SA
    Acta Paediatr Scand Suppl; 1989; 362():56-60. PubMed ID: 2485601
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.